Safety and Tolerability of TG1050: A Dose-finding Study
NCT02428400
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
BIOLOGICAL:
TG1050
BIOLOGICAL:
Placebo
Sponsor
Transgene